Bionime Corporation (TPE:4737)

Taiwan · Delayed Price · Currency is TWD

57.10

-1.20 (-2.06%)

Jul 30, 2026, 12:16 PM CST

-15.59% (1Y)

Market Cap	4.51B -0.9%
Revenue (ttm)	1.76B -9.5%
Net Income	-247.64M
EPS	-3.60
Shares Out	77.29M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	52,001
Open	59.10
Previous Close	58.30
Day's Range	55.90 - 59.10
52-Week Range	49.75 - 73.90
Beta	-0.12
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 10, 2026

About Bionime

Bionime Corporation designs, manufactures, and sells medical instruments in China, Switzerland, the United States, Belarus, Algeria, the United Arab Emirates, Egypt, and internationally. The company manufactures and sells blood glucose meters and test strips to medical equipment companies, pharmacies, and hospitals, as well as offering blood glucose monitoring devices and systems under the RIGHTEST brand; a continuous glucose monitoring system under the iFree CGM brand; and medical blood glucose management systems. It is also involved in the pr... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 2003

Employees 500

Stock Exchange Taiwan Stock Exchange

Ticker Symbol 4737

Full Company Profile

Financial Performance

In 2025, Bionime's revenue was 1.84 billion, a decrease of -4.92% compared to the previous year's 1.93 billion. Losses were -180.28 million, 41.7% more than in 2024.

Financial Statements